Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
PLoS One ; 10(10): e0139677, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26509441

RESUMO

BACKGROUND: Immunological and virological status of HIV-infected individuals entering the Brazilian public system over time was analyzed. We evaluated the impact of ART on virological, immunological and antiretroviral resistance over time. METHODS: CD4+ T cell counts, viral loads and genotypes from patients over 13 years old from 2001-2011 were analyzed according to demographic data. We compared groups using parametric t-tests and linear regression analysis in the R statistical software language. RESULTS: Mean baseline CD4+ T cell counts varied from 348 (2003) to 389 (2009) and was higher among women (p = 1.1 x 10(-8)), lower in older patients (p< 1 x 10(-8)) and lower in less developed regions (p = 1.864 x 10(-5)). Percentage of treated patients with undetectable viral loads increased linearly from 46% (2001) to 77% (2011), was lower among women (p = 2.851 x 10(-6)), younger ages (p = 1 x 10(-3)), and in less developed regions (p = 1.782 x 10(-4)). NRTI acquired resistance was 86% in 2001-3 and decreased over time. NNRTI resistance increased from 2001-3(50%) to 2006-9 (60%), PI resistance decreased from 2001-3 (60%) to 2009 (40%), and 3-class resistance was stable over time around 25%. Subtype prevalence comprised B (75.3%), B/F recombinants (12.2%), C (5.7%), F (5.3%) and B/C recombinants (1.5%), with regional variations. Three-class resistance was 26.5% among Bs, 22.4% among Fs and 17.2% among Cs. CONCLUSIONS: HIV diagnosis occurs late, especially among elderly Brazilians. Younger individuals need special attention due to poor virological response to treatment. Antiretroviral Resistance profile is subtype related.


Assuntos
Terapia Antirretroviral de Alta Atividade , Infecções por HIV/imunologia , Infecções por HIV/virologia , Adolescente , Adulto , Brasil , Contagem de Linfócito CD4 , Farmacorresistência Viral , Feminino , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Humanos , Limite de Detecção , Masculino , Pessoa de Meia-Idade , Carga Viral , Adulto Jovem
2.
J Int AIDS Soc ; 14: 45, 2011 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-21936945

RESUMO

The Brazilian network for genotyping is composed of 21 laboratories that perform and analyze genotyping tests for all HIV-infected patients within the public system, performing approximately 25,000 tests per year. We assessed the interlaboratory and intralaboratory reproducibility of genotyping systems by creating and implementing a local external quality control evaluation. Plasma samples from HIV-1-infected individuals (with low and intermediate viral loads) or RNA viral constructs with specific mutations were used. This evaluation included analyses of sensitivity and specificity of the tests based on qualitative and quantitative criteria, which scored laboratory performance on a 100-point system. Five evaluations were performed from 2003 to 2008, with 64% of laboratories scoring over 80 points in 2003, 81% doing so in 2005, 56% in 2006, 91% in 2007, and 90% in 2008 (Kruskal-Wallis, p = 0.003). Increased performance was aided by retraining laboratories that had specific deficiencies. The results emphasize the importance of investing in laboratory training and interpretation of DNA sequencing results, especially in developing countries where public (or scarce) resources are used to manage the AIDS epidemic.


Assuntos
Infecções por HIV/virologia , HIV-1/classificação , HIV-1/genética , Tipagem Molecular/normas , Garantia da Qualidade dos Cuidados de Saúde/métodos , Virologia/normas , Brasil , Humanos , Variações Dependentes do Observador , Controle de Qualidade , Reprodutibilidade dos Testes
3.
J Clin Virol ; 49(4): 245-8, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20880740

RESUMO

BACKGROUND: Utilization of dried plasma for HIV-1 viral load testing would significantly decrease sample shipping costs. OBJECTIVES: To describe the precision and reproducibility of ViveST(®) (ST) as a transportation method for shipping specimens for HIV-1 viral load (VL) testing. STUDY DESIGN: Thirty clinical plasma samples were used to generate replicate samples with HIV VL values of 4 log(10), 3 log(10) and 2 log(10) copies/mL for reproducibility testing and an additional 299 samples with HIV VL <50 copies/mL (99); 1.7 log(10) to 3.99 log(10) (100); and 4 log(10) to 5.99 log(10)/mL (100) were used to compare ViveST to frozen plasma samples using the VERSANT(®) HIV-1 RNA 3.0 Assay. Results were compared using Student t-test, Pearson correlation and Bland-Altman analyses. RESULTS: Mean intra-assay variance among frozen and dried plasma triplicates was 0.15 log(10) and 0.09 log(10) copies/mL respectively (n=10, P=NS). Compared to frozen plasma, there was a mean reduction of 0.3 log(10), 0.27 log(10), and 0.35 log(10) copies/mL at the 4 log(10), 3 log(10), and 2 log(10) copy/mL samples respectively (n=30, all comparisons, P<0.01). Overall correlation between 299 frozen and ViveST samples was r=0.97, where 12 of 99 undetectable frozen VL were positive with ST, and 12 of 200 frozen detectable VL were undetectable with ViveST (mean VL 2.1, 1.9 log(10) copies/mL respectively). CONCLUSIONS: HIV-1 viral load results using ViveST were reproducible, correlated well with frozen plasma, though yielding minimally lower values. Our data suggest that dried plasma for HIV-1 VL testing using ViveST has promise for use in HIV clinical practice.


Assuntos
Dessecação , Infecções por HIV/diagnóstico , Infecções por HIV/virologia , HIV-1/isolamento & purificação , Plasma/virologia , Manejo de Espécimes/métodos , Carga Viral/métodos , Brasil , Humanos , Reprodutibilidade dos Testes
4.
J Int AIDS Soc ; 12: 20, 2009 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-19765271

RESUMO

Use of antiretrovirals is widespread in Brazil, where more than 200,000 individuals are under treatment. Although general prevalence of primary antiretroviral resistance in Brazil is low, systematic sampling in large metropolitan areas has not being performed.The HIV Threshold Survey methodology (HIV-THS, WHO) was utilized, targeting Brazil's four major regions and selecting the six most populated state capitals: Sao Paulo, Rio de Janeiro, Salvador, Porto Alegre, Brasilia and Belem. We were able to sequence samples from 210 individuals with recent HIV diagnosis, 17 of them (8.1%) carrying HIV isolates with primary antiretroviral resistance mutations. Five, nine and four isolates showed mutations related to resistance to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), respectively. Using HIV-THS, we could find an intermediate level of transmitted resistance (5% to 15%) in Belem/Brasilia, Sao Paulo and Rio de Janeiro. Lower level of transmitted resistance (<5%) were observed in the other areas. Despite the extensive antiretroviral exposure and high rates of virologic antiretroviral failure in Brazil, the general prevalence of primary resistance is still low. However, an intermediate level of primary resistance was found in the four major Brazilian cities, confirming the critical need to start larger sampling surveys to better define the risk factors associated with transmission of resistant HIV.

5.
J. pediatr. (Rio J.) ; 76(3): 237-40, maio-jun. 2000.
Artigo em Português | LILACS | ID: lil-268353

RESUMO

Objetivo: Apresentar o caso de uma menina previamente hígida, com evolução fatal devido a meningoencefalite por víirus Coxsackie B2. Métodos: Os autores descrevem um caso de uma criança do sexo feminino com, meningoencefalite fatal por vírus Coxsackie B2 e apresentam revisão da literatura (Medline e Licacs). Resultados: É descrito um caso de uma menina de oito anos de idade, que apresentou quadro meningoencefalítico de má evolução, resultando em óbito no 32§ dia de internação. Os exames realizados mostraram sorologia positiva para Coxsackie B2, sendo o vírus isolado de duas amostras de fezes. O exame liquórico mostrou aumento maior que quatro vezes na titulação para Coxsackie B2. Conclusões: A evolução para óbito de pacientes hígidos apresentando encefalite por enterovírus, conforme o descrito, é pouco referido na literatura, talvez por falta de suspeita clínica. O relato deste caso demonstra a importância do diagnóstico etiológico precoce nas meningoencefalites e da busca de tratamento etiológico específico


Assuntos
Feminino , Criança , Enterovirus , Enterovirus Humano B , Meningoencefalite
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA